Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients

Status: Completed
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To investigate the role of KATP channels in migraine with aura patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Migraine with aura patients of both sexes.

• 18-60 years.

• 50-100 kg.

Locations
Other Locations
Denmark
Danish headache center
Glostrup Municipality
Time Frame
Start Date: 2019-07-09
Completion Date: 2019-12-10
Participants
Target number of participants: 17
Treatments
Active_comparator: Levcromakalim
Placebo_comparator: Saline
Sponsors
Leads: Danish Headache Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.